Aproviso(Richboro, Pennsylvania), a provider of secure technologies for the life science and healthcare industries, andVista Clinical, which focuses on clinical trial automation technology, reported that they have formed a strategic partnership to deliver next-generation clinical trial automation technologies to the medical device, biotech and pharmaceutical industries.

The accord combines validation, hosting, deployment and support services provided by Aproviso with a new, next-generation clinical trial automation platform developed by Vista. The combination delivers the most powerful technology available under an independent certification (validation) together with a customer-centric focus on deployment and support, the companies said.